Comparison results
| Results: Differences Similar | ✘C74 | ✘C96.2 | ||||||||||
| Related research | Analogs | Analogs | ||||||||||
| ||||||||||||
| Distinctive symptoms | ||||||||||||
| Register, to see more distinctive signs of diseases and studies | 100% | — | ||||||||||
| Register, to see more distinctive signs of diseases and studies | — | 47% | ||||||||||
| pheochromocytoma | 84% | — | ||||||||||
| feeling of fullness | — | 26% | ||||||||||
| high risk of prostate cancer | 61% | — | ||||||||||
| chronic myeloid leukemia | — | 22% | ||||||||||
| metastases | 51% | — | ||||||||||
| myelofibrosis | — | 22% | ||||||||||
| insulinoma | 49% | — | ||||||||||
| chronic leukemia | — | 21% | ||||||||||
| lee-fraumeni syndrome | 48% | — | ||||||||||
| myeloid metaplasia | — | 20% | ||||||||||
| tumors of the parathyroid glands | 47% | — | ||||||||||
| chronic lymphocytic | — | 18% | ||||||||||
| neuroblastoma | 47% | — | ||||||||||
| hemorrhagic syndrome | — | 17% | ||||||||||
| brain tumors in children | 46% | — | ||||||||||
| multiple organ failure | — | 16% | ||||||||||
| facial hair growth | 46% | — | ||||||||||
| aggressive | — | 13% | ||||||||||
| breast sarcoma | 43% | — | ||||||||||
| control issues | — | 12% | ||||||||||
| itsenko-cushing syndrome (hypercorticism) | 41% | — | ||||||||||
| patient's condition | — | 11% | ||||||||||
| discomfort in the chest | 40% | — | ||||||||||
| hyperaldosteronism | 40% | — | ||||||||||
| prostate cancer | 40% | — | ||||||||||
| vascular tumor | 40% | — | ||||||||||
| muscle weakness | 39% | — | ||||||||||
| pancreatic cancer | 39% | — | ||||||||||
| pituitary tumors | 39% | — | ||||||||||
| weakness of the muscles of the hands | 38% | — | ||||||||||
| impaired prostate function | 38% | — | ||||||||||
| posttransfusion complications | 37% | — | ||||||||||
| fat deposits | 36% | — | ||||||||||
| brain cancer | 36% | — | ||||||||||
| benign epithelial tumors | 36% | — | ||||||||||
| weakness in the hands | 35% | — | ||||||||||
| weakness | 35% | — | ||||||||||
| thin skin | 35% | — | ||||||||||
| breast cancer | 35% | — | ||||||||||
| ones weakness in the leg muscles | 35% | — | ||||||||||
| solid tumors | 34% | — | ||||||||||
| cns tumors | 34% | — | ||||||||||
| effects of radiation therapy | 34% | — | ||||||||||
| weakness in the legs | 33% | — | ||||||||||
| bone tumors | 33% | — | ||||||||||
| serum sickness | 33% | — | ||||||||||
| breast cancer | 33% | — | ||||||||||
| breast tumor | 33% | — | ||||||||||
| oncology relatives | 33% | — | ||||||||||
| effects of taking hormones | 32% | — | ||||||||||
| brain tumor | 32% | — | ||||||||||
| illness from stress | 31% | — | ||||||||||
| fainting | 31% | — | ||||||||||
| brain tumor | 30% | — | ||||||||||
| cancer | 55% | 24% | ||||||||||
| disorders of consciousness | 29% | — | ||||||||||
| adaptation disorders | 29% | — | ||||||||||
| radiation therapy | 29% | — | ||||||||||
| oncology | 52% | 22% | ||||||||||
| radiation damage | 28% | — | ||||||||||
| tachycardia | 28% | — | ||||||||||
| scarring | 28% | — | ||||||||||
| benign neoplasms | 28% | — | ||||||||||
| hormonal disorders | 27% | — | ||||||||||
| diabetes mellitus | 27% | — | ||||||||||
| palpitations | 27% | — | ||||||||||
| headaches | 27% | — | ||||||||||
| recovery period | 26% | — | ||||||||||
| consequences of operation | 25% | — | ||||||||||
| there are no complaints | 25% | — | ||||||||||
| blood diseases | 34% | 16% | ||||||||||
| consequences of taking medications | 24% | 11% | ||||||||||
| leukemia | 34% | 27% | ||||||||||
| lymphocytic | 34% | 27% | ||||||||||
Instructions
Video 
|
